Market Share of Germany Insulin Drugs And Delivery Devices Industry
The Germany Insulin Drugs and Delivery Devices Market is moderately consolidated, with few significant and generic players. Mergers and acquisitions between the players recently have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance in developing and commercializing Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.
Germany Insulin Drugs And Delivery Devices Market Leaders
Medtronic
Ypsomed
Novo Nordisk A/S
Eli Lilly and Company
Sanofi Aventis
*Disclaimer: Major Players sorted in no particular order
